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A B S T R A C T
Infection with oncogenic human papillomavirus induces deregulation of cellular redox homeostasis. Virus
replication and papillomavirus-induced cell transformation require persistent expression of viral oncoproteins
E7 and E6 that must retain their functionality in a persistent oxidative environment. Here, we dissected the
molecular mechanisms by which E7 oncoprotein can sense and manage the potentially harmful oxidative
environment of the papillomavirus-infected cell. The carboxy terminal domain of E7 protein from most of the
79 papillomavirus viral types of alpha genus, which encloses all the tumorigenic viral types, is a cysteine rich
domain that contains two classes of cysteines: strictly conserved low reactive Zn+2 binding and degenerate
reactive cysteine residues that can sense reactive oxygen species (ROS). Based on experimental data obtained
from E7 proteins from the prototypical viral types 16, 18 and 11, we identiﬁed a couple of low pKa nucleophilic
cysteines that can form a disulﬁde bridge upon the exposure to ROS and regulate the cytoplasm to nucleus
transport. From sequence analysis and phylogenetic reconstruction of redox sensing states we propose that
reactive cysteine acquisition through evolution leads to three separate E7s protein families that diﬀer in the ROS
sensing mechanism: non ROS-sensitive E7s; ROS-sensitive E7s using only a single or multiple reactive cysteine
sensing mechanisms and ROS-sensitive E7s using a reactive-resolutive cysteine couple sensing mechanism.
1. Introduction
Reactive oxygen species (ROS) are a broad set of chemical oxidants,
which include hydrogen peroxide (H2O2), superoxide anion (·O2-),
hydroxyl radicals (·OH) and singlet oxygen (1O2), all involved in
harmful and vital cellular processes [1,2]. The “dark side” of ROS
involves the unwanted oxidation of proteins, lipid peroxidation, and
DNA damage [3]. However, H2O2 is necessary for cell signaling and
mediates vital processes such as hypoxic signal transduction, cell
diﬀerentiation, proliferation, angiogenesis, apoptosis and immune
response [4]. For cell signaling purposes, ROS are enzymatically
produced in a deﬁned time, on a deﬁned cell compartment and upon
speciﬁc stimuli by NAD(P)H oxidases or NADPH oxidases (NOXs) [5].
NOXs produce superoxide anion that is readily converted to H2O2 by
superoxide dismutase (SOD). The homeostasis of redox balance that
governs the pros and cons of ROS is based on an intertwined network
of redox enzymes such as SOD, catalase, thioredoxin and peroxiredoxin
[1,6] along with a plethora of redox-responsive proteins that includes
transcription factors such as Nrf2 [7] or FOXO [8] and redox-sensitive
kinase such as Src [9].
A direct link between ROS and cancer development has been
recently established [10,11] where tumor cells show an altered ROS
production resulting in the up-regulation of peroxide-dependent
signaling pathways that regulate cell diﬀerentiation, growth and
survival. A well-established case of this association is the eﬀect of
human papillomavirus (HPV) replication on infected and transformed
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cells, where the overall redox balance is deregulated [12–15].
Papillomavirus are small DNA tumor viruses that are the causative
agents of cervical cancer [16] and common warts [17]. Only a small
fraction of the infected cells will eventually progress to cancer in a
process that requires, at least, the persistent expression of E7 and E6
oncogenes [18] and an unknown triggering factor. In this scenario, it
was suggested that the oxidative damage induced in HPV-infected cells
could be the factor that eventually cooperates with viral oncoproteins to
trigger cancer progression, in a very rare event.
Accumulated evidence supports the correlation between oxidative
stress and HPV-induced transformation: i) ERp57 and GST involved in
redox homeostasis were sharply elevated in dysplastic and neoplastic
HPV-induced lesions [13]. ii) Oxidative damage reported by the
increase of plasma malondialdehyde was demonstrated for patients
with cervical intraepithelial neoplasia and cervical carcinoma [19], and
an increase in the overall levels of protein oxidation was demonstrated
in HPV-infected cells [13]. iii) The over-expression of NOX 1 accel-
erates neoplastic progression of human gingival mucosal keratinocytes
immortalized by HPV16 E6/E7 [20,21]. iv) The solely expression of
HPV16 E6 and E7 proteins induces a chronic oxidative stress response
via NOX 2 [22].
We focused on the E7 oncoprotein, a 100 amino-acid protein with
two well deﬁned domains that diﬀer in their conformational and
functional properties [23]. The amino terminal domain (E7N, ca. 40
residues) is devoid of stable secondary and tertiary structure and shows
properties resembling the intrinsically disordered domains. The E7N
contains the highly conserved LXCXE motif, which is responsible for
the high binding aﬃnity of the retinoblastoma protein (Rb) [24]. The
carboxy terminal domain (E7C, ca. 50 residues) is a well-folded domain
with a globular hydrodynamic behavior. The E7C bears a tetracysteine
Zn binding motif, unique among papillomavirus, and is composed of
the CXXC-X29-CXXC sequence. These four cysteines are highly con-
served and Zn+2 coordination plays an essential structural role. The
E7C is the oligomerization domain and is responsible for the dimeric
structure observed in the published structures [24,25]. Still, a Kd of
1 µM indicates that the protein forms weak dimers along with the
monomeric state and has been proved to be functional for transforma-
tion [26,27]. The four cysteines present in the E7C (Zn+2 binding
motif) together with the cysteine in the LXCXE motif of E7N are
considered as canonical cysteines. These ﬁve residues are highly
conserved and are present in most of the E7 sequences regardless
the genus, species or viral types. Many HPV types show an increased
number of cysteines besides the canonical residues; however, these
cysteines are much less conserved and we name them as non-canonical
cysteines [28].
Along with the diﬀerent conformational properties of the E7N and
E7C, we previously showed that the cysteine residues in each domain,
at least for HPV16, constitute diﬀerent redox centers [29]. The cysteine
residue located within the Rb binding motif (LXCXE) is sensitive to
gluthationylation and this modiﬁcation abolishes the binding of Rb. On
the other hand, we have recently shown that the non-canonical
cysteines, C59 and 68 in HPV16 E7, form a disulﬁde bond when
exposed to an oxidative environment where the tetrahedral Zn+2
binding motif remains unaﬀected [29]. We further demonstrated that
each domain can be oxidized independently and a mutant that lacks the
LXCXE motif is able to form the observed disulﬁde bond.
The structures of the E7 proteins for the viral types HPV1a and
HPV45 are dimeric and superimposable, and it is well accepted that the
overall fold is a common feature of all E7s. It should be noted that
residues 59 and 68 in the dimeric structure are 18.6 Å apart, too far to
form a disulﬁde bridge. Therefore, an intermediary is more likely to
occur [29].
In this work, we address the chemical mechanism by which a
cysteine-rich oncoprotein senses and responds to the redox stimuli in
an HPV-infected cell and how the protein can manage the potentially
harmful oxidative environment of a tumor tissue. We address the
diﬀerential conservation pattern and functional properties of canonical
and non-canonical residues in the E7 proteins of alpha genus papillo-
mavirus.
2. Methods
2.1. Protein expression and puriﬁcation
Recombinant proteins were expressed in E. coli BL21(DE3)pLysS.
Wild type E7 from HPV16 and cysteine-substituted mutants
E7desLXCXE and HPV16E7(C59/68A) accumulate in inclusion bodies
as fusions to a 19-aminoacid beta-galactosidase peptide with an
enterokinase (EK) cleavage site as linker. The detailed puriﬁcation
protocol was previously described [30]. The truncated gene coding
HPV16 E7Δ1–26 was cloned into a pMAL-c2 vector (New England
Biolabs). The recombinant protein was puriﬁed as described for the full
length HPV16 E7 rendering the E7Δ1–26 with two N-terminal
aminoacids (glycine and serine) due to MBP excision with thrombin
protease. GST-tagged wild type E7 from HPV11 and HPV18 were
puriﬁed from soluble bacterial extracts in a glutathione-sepharose
column. Untagged HPV11 E7 and HPV18 E7 were also obtained by
thrombin cleavage.
A ﬁnal puriﬁcation step in a Superdex 75 column (GE Healthcare
Bio-Sciences Corp, USA) with a reducing agent-free buﬀer was
performed for all proteins. Purity was > 95% as conﬁrmed by PAGE,
with no more than 10% of oxidized species. Concentrated reductant-
free protein stocks were maintained at -80C for 3 months with no
oxidative damage.
2.2. Sequence alignment and naïve model for cysteine distribution
We retrieved all alpha genus papillomavirus types in the NCBI
taxonomy database as October 1, 2015. At least 79 alpha-papilloma-
virus types had one ORF coding for E7 protein. Alignments for HPV E7
protein sequences were performed using the MUSCLE algorithm [31]
and manually edited using the SeaView software. Naïve model for
cysteine distribution were generated by a randomized assignment of
cysteines at diﬀerent positions in the sequence. To build the model this
procedure was repeated 10000 times, the mean and standard deviation
values for each combination of cysteines were calculated.
2.3. Ancestral states reconstruction and randomized trees
The tracing of the ancestral redox sensing state of each internal
node was done using Mesquite and choosing reconstruction by
parsimony [32]. The transformation types were deﬁned as unordered,
in which any state is allowed to transform to any other with one step of
evolution. Each transition of states between nodes was counted. The
redox state reconstructions from randomized trees were generated by
reshuﬄing the same terminal taxa without altering the tree structure to
obtain 100,000 trees. For each tree the ancestral redox state was
reconstructed by parsimony using Mesquite and all transitions between
node states were counted.
2.4. Quantitative thiol and Zn determination
Thiol content was quantiﬁed using DTNB; Zn content was deter-
mined using PAR-PMPS methods as described in [49].
2.5. Reactivity to H2O2 by RP-HPLC
Oxidation was triggered by the addition of 0.15 mM of H2O2 to a
solution containing 3.5 µM of reduced protein in 50 mM potassium
phosphate buﬀer pH 7.5, incubated at 37 °C. Samples were taken at the
stated time; methionine was added to 2.5 mM ﬁnal concentration to
quench peroxide and immediately injected into a reverse phase HPLC
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(RP-HPLC). Isolation was performed using a C4 column,
250 mm×4.6 mm (Bio-Basic-C4, Thermo Scientiﬁc, PA, USA) and the
eluted species were detected with a diode-array detector.
For the apparent t1/2 estimation, the peak area of each species was
quantiﬁed, plotted versus time and ﬁtted to a single exponential
according to Eq. (1).
Y e= 100 k t(− . ) (1)
where Y is the remaining amount of the species at a deﬁned time and k
is the apparent oxidation constant. The apparent t1/2 is calculated using
the Eq. (2).
t
k
= ln 21/2 (2)
2.6. Circular dichroism
CD measurements were carried out on a Jasco J-810 spectro-
polarimeter (Jasco, Easton, MD) employing a scan speed of 50 nm/
min, a 4 nm band pass and an average response time of 4 s, at 37 °C in
a Peltier temperature–controlled sample compartment. Spectra were
an average of at least 6 scans. Spectra of reduced and oxidized 20 µM
E7 were taken on 0.1 cm path length cells in 10 mM potassium
phosphate buﬀer, pH 7.5. Oxidation was triggered by adding
0.15 mM H2O2 to the reduced protein in the CD cell.
2.7. Cysteine pKa determination
We prepared samples containing 3.5 µM of reduced E7Δ1–26
protein in 50 mM of the following buﬀers: sodium acetate (pH 5.0),
potassium phosphate (pH 6.0; 6.5; 7.0 and 8.0) and Tris-HCl (9.0 and
10.0). The oxidation reaction was initiated by the addition of 0.15 mM
of H2O2. After one hour of incubation at 37 °C methionine was added
to 2.5 mM ﬁnal concentration to quench peroxide and the reaction was
stopped by acidiﬁcation with 0.1% TFA. The mixture was resolved by
RP-HPLC (see Reactivity to H2O2 by RP-HPLC). The pKa of the
reactive cysteine was determined by analyzing two diﬀerent species. A
plot of the Ox II species formation and the decrease of the reduced
species versus pH was obtained and ﬁtted to Eq. (3). The decrease of
the reduced species was obtained by subtracting 100 – (%) of reduced
peak.
APeak Intensity(%) =
(1 + 10 )pKa pH( − ) (3)
A is a constant.
2.8. Disulﬁde connectivity by MALDI-TOF
Reduced, Ox I and Ox II species from diﬀerent proteins were
isolated by RP-HPLC and lyophilized. Dry samples were resuspended
with an alkylating solution containing 56 mM Iodoacetamide in order
to block reactive sulfhydryls. Samples were precipitated with TCA and
the acetone-washed dry pellets resuspended with 50 mM Tris-HCl,
5 mM Octyl β-D-glucopyranoside, pH 8.0 containing sequencing grade
trypsin (Sigma, St Louis, MO) at 1/10 (w/w). Ultra-pure 5 mM DTT
was added when required. After 4 h proteolysis at 37 °C the reaction
was stopped by adding 0.1% TFA. A 1 µL aliquot was spotted onto an
AnchorChip (Bruker, Billerica, MA, USA) and 1 µL oversaturated
solution of α-Cyano-4-hydroxycinnamic Acid in 30/70/0.1% (v/v)
acetonitrile/water/TFA was loaded to the protein. Samples were
analyzed on a Bruker Microﬂex MALDI-TOF.
2.9. Transient expression of spGFP fusion proteins in Hela cells and
ﬂuorescence microscopy
HeLa cells were plated on 12 mm glass coverslips to 80% con-
ﬂuency, transfected 24 h later with spGFP-E7wt, spGFP-E7C59A or
spGFP plasmids using Lipofectamine 2000 (Invitrogen) and ﬁxed 24 h
after transfection with 4% formaldehyde. For ROS treatment, cells were
incubated with 4 µM H2O2 for 1 h prior to ﬁxation. Coverslips were
mounted using Mowiol mounting medium and cells were observed by
ﬂuorescence microscopy using a Zeiss LSM 510 confocal (Carl Zeiss,
Thornwood, NY).
Quantiﬁcation of the subcellular localization of spGFP-E7wt,
spGFP-E7C59A and spGFP proteins was performed by analyzing
ﬂuorescence intensity of random circular regions of interest (ROIs)
in nuclear and cytoplasmic areas using ImageJ software. Data from at
least 20 cells and 5 ROIs per cell were used for the quantitative
analysis; graphical representation displays average values with stan-
dard deviation. Signiﬁcance of diﬀerences among groups was tested by
one-way ANOVA and Holm-Sidak method was used for post hoc
testing. SigmaStat 4.0 (Systat Software Inc.) was used to perform all
calculations. Diﬀerences were considered signiﬁcant if P≤0.05. Data
are expressed as mean ± SD.
2.10. Western-blot
Hela cells were transfected as indicated above and lysates were
obtained 24 h post-transfection using RIPA buﬀer. Extracts were
electrophoresed using 12.5% SDS-polyacrylamide gels, and transferred
to nitrocellulose membrane; blots were probed with anti HPV16 E7
monoclonal antibody.
3. Results
3.1. Cysteine conservation pattern in E7C
Cysteine residues are highly reactive due to the nucleophilic
character of the thiolate group, and their conservation is often related
to function [33]. In this regard, the high content and conservation of
cysteine residues in E7 protein are likely to be connected to the
molecular basis for redox sensing. E7 contains ﬁve highly conserved
canonical cysteine residues, one in E7N and four in E7C (Fig. 1A). In
addition, most (94%) E7 proteins from the alpha genus possess one to
three extra, non-canonical cysteine residues in E7C (Fig. 1B) and can
be considered a cysteine rich domain (CRD).
Our alignment of 79 sequences from alpha papillomaviruses shows
that non-canonical cysteines are not evenly distributed but occupy a
narrow set of 15 positions in the E7C (Fig. 1C). The appearance of a
particular non-canonical cysteine can be observed in viral types
belonging to diﬀerent species and infecting diﬀerent hosts (Fig. 1 C).
For example, the non-canonical cysteine at position 71 is present in 32
out of 79 viral types spanning species 1, 2, 3, 4, 8, 10 and 14. Moreover,
29 of these viral types infect humans while the remaining three are
simian papillomaviruses. All thirteen high-risk HPV viral types belong
to species 7 and 9 in the alpha genus and show at least one non-
canonical cysteine, with 12 out of 13 showing two non-canonical
cysteines (Fig. 1C).
3.2. Non-canonical residues of E7 cysteine rich domain are primary
targets of ROS
With the aim of evaluating the sensitivity of HPV16 E7 protein to
ROS, we resolved and quantiﬁed the oxidized species that are formed
by the addition of H2O2 by RP-HPLC. Within the ﬁrst hour of reaction
with peroxide, we observed the decrease of the reduced protein (RT:
28.7 min) with the appearance of peaks at 24.8 min and 21.9 min,
indicated as Ox I and Ox II species, respectively, (Fig. 2A and
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Supplementary 1). Using glutathione redox buﬀer as an oxidant stimuli
we have previously observed the formation of Ox II species that were
originated by the disulﬁde formation between non-canonical cysteines
59 and 68 in the E7 HPV16 protein [29].
Less than 40% of E7 protein remains in the reduced state after one
hour of H2O2 incubation, with an apparent t1/2 decay of the reduced
peak of 40.7 min (Fig. 2B and C). After the ﬁrst hour, the intensity of
reduced, Ox I and Ox II species decreases with the appearance of a
broad set of peaks that cannot be chromatographically resolved for the
E7 wild type and are marked, altogether as Ox III species. After
240 min of H2O2 treatment, less than 5% of the protein remains in the
reduced state and a wide peak of over-oxidized species (Ox III) is
observed (Fig. 2A and Supplementary 1).
We decided to further assess the location of the main ROS sensitive
cysteines on E7 protein. Two mutants where the canonical cysteine 24
(C24) has been mutated (E7desLXCXE) or deleted (E7Δ(1-26))
(Fig. 2C) were oxidized with H2O2 with the formation of Ox I and Ox
II species within the ﬁrst hour (Fig. 2A and Supplementary 1). The
Fig. 1. E7 alpha papillomavirus cysteine distribution. (A) E7 dimer structure. The globular E7C domain (pink circle) contains four canonical cysteines (green) that coordinate the Zn+2
atom (green spheres), the ﬁfth canonical cysteine is located in the E7N unstructured domain (LXCXE motif; green); positions most frequently occupied by non-canonical cysteines in
E7C are depicted in red (cysteine frequency above the average percentage observed in mammalian proteins (2.3%) are located at the positions 51, 56, 57, 59, 63, 68 and 71). (B)
Distribution of the number of non-canonical cysteines in the E7C of alpha genus papillomavirus. (C) Schematic distribution of the cysteines in the E7C. Canonical cysteines are indicated
in green and non-canonical in red. The sequences are ordered according to the alpha genus phylogenetic tree (left) with the specie number indicated at the right. Above the scheme, the
motif logo of the 79 sequences is shown. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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presence of the C59-S-S-C68 disulﬁde in the Ox II peak was conﬁrmed
for the E7Δ(1-26) protein. The apparent t1/2 for the reduced peak decay
of E7desLXCXE and E7Δ(1-26) is 22.4 and 34.5 min, respectively
(Fig. 2B and C) comparable with the decay of the wild type E7, strongly
suggesting that a ROS sensitive cluster of cysteines is located in the
E7C CRD. The decrease of the reduced species in the wild type, the
desLXCXE and the E7Δ(1-26) proteins occur with the concomitant
formation of a disulﬁde bridge between non-canonical cysteines 59 and
68 (Ox II species).
In a mutant where both non-canonical cysteines are replaced by
Fig. 2. ROS sensitivity of HPV16 E7 protein and mutants. (A) RP-HPLC chromatograms of HPV16 E7 wild type, E7desLXCXE, E7Δ1–26 and E7(C59/68 A) incubated for 0 (black
line), 60 (red line) and 240 min (blue line) with hydrogen peroxide. R indicates the reduced species peak. * indicates an unidentiﬁed peak. (B) Kinetic decay of the reduced species. The
reduced species was quantiﬁed by the area of the reduced peak (R). HPV16 E7 wild type (black circles), E7desLXCXE (blue circles), E7Δ1–26 (green circles) and E7(C59/68 A) (red
circles). (C) Schematic representation of the HPV16 E7 wild type, E7desLXCXE, E7Δ1–26 and E7(C59/68 A). The apparent t1/2 decay for the reduced species is shown at the right side
of each protein. Apparent t1/2 was calculated by ﬁtting to a single exponential equation. Green squares represent the position of canonical cysteines and red squares represent non-
canonical residues. (D) Evolution proﬁle of the reduced (black circles and line), Ox II species (red circle and line) and Ox III (blue circles and line) of the E7desLXCXE protein. (F)
Evolution proﬁle of the reduced (black circles and line) and Ox III (blue circles and line) of the E7(C59/68 A) protein. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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alanine, E7(C59/68 A), the Ox II species is absent (Fig. 2A and
Supplementary 1) and is more refractory to ROS. After one hour of
reaction over 75% of the E7(C59/68 A) is still reduced, with an
apparent t1/2 of 117 min (Fig. 2B). On the other hand, the formation
of overoxidized Ox III species was observed for all of the four proteins
analyzed, an event that is clearly evident after 240 min of incubation
(Fig. 2A and Supplementary 1).
This multi-step process is clearly observed for the E7desLXCXE
protein where the Ox I, Ox II and Ox III species can be accurately
quantiﬁed (Fig. 2D). On the other hand, the double cysteine mutant
decays slowly, with the concomitant appearance of the overoxidized Ox
III species and a minor proportion of Ox I (see Fig. 2E and
Supplementary 1). After 240 min of incubation, the reduced fraction
of E7(C59/68A) protein is 30% (Fig. 2B).
These results show that the redox-sensitive residues that generate
the oxidized species I, II and III are contained in the CRD of E7; where
Ox II, originated in the formation of C59-S-S-C68 disulﬁde bond, is the
major species and its appearance occurs concomitant with the decay of
the reduced protein. On the other hand, Ox I and Ox III that are also
observed for E7(C59/68A) protein correspond to a modiﬁcation in the
canonical cysteines or other redox sensitive residues such as methio-
nine. As the formation of Ox I, Ox II and Ox III is reversible with DTT
(not shown) we can exclude methionine or other non-reversible
oxidations.
3.3. E7 proteins containing diﬀerent arrangements of non-canonical
cysteines show similar reactivity to ROS
E7 proteins of diﬀerent strains contain a diﬀerent combination of
non-canonical cysteines and these are oxidized by H2O2 to the same
extent than the wt HPV16 E7. The E7 protein from viral types 11 and
18 contain three and two non-canonical cysteines, respectively. The
distribution pattern of the non-canonical cysteines is diﬀerent for the
three proteins yet they share cysteine 59 (refers to the position in the
HPV16 E7 sequence) (Fig. 3A). We ﬁrst determined that HPV16,
HPV11 and HPV18 E7 proteins contain one Zn+2 atom strongly bound
(over 90% occupancy, not shown) and the quantitation of the thiol
content by DTNB yielded that 95%, 90% and 85% of the cysteines in
HPV16, HPV11 and HPV18 E7 proteins were reactive, indicating that
the proteins are reduced and accessible the storage conditions (not
shown).
The incubation of these proteins with 0.15 mM H2O2 at 37 °C and
pH 7.4 led to a decrease of the reduced peak, with an apparent t1/2 of
17.3 and 34.6 min for the HPV11 and HPV18, respectively. The decay
of the reduced peak for HPV11 and 18 E7 is similar to that observed for
the HPV16 E7 protein (Fig. 3B) indicating that both proteins are highly
sensitive to ROS. As in the case of the HPV16 protein, within the ﬁrst
hour of reaction the HPV11E7 and HPV18E7 reduced species decrease
with the concomitant increase of intermediate oxidized species. After
one hour these intermediate species are transformed in the over-
oxidized species that could not be resolved by RP-HPLC and were
observed as a broad sum of peaks (Supplementary Figure 2).
The major species observed in the HPV16 E7 protein after one hour
of incubation with peroxide is the Ox II peak that corresponds to the
formation of a disulﬁde bond between cysteine 59 and 68. We obtained
a three-dimensional model for the HPV16 E7 proteins using the HPV1
E7 structure as a template [34]. The sulfur atoms of the C59 and C68
are 19.2 A distant in the dimeric structure of the HPV16 E7, a distance
that is too extensive to allow a direct (SN2 mechanism) disulﬁde
formation (the cut oﬀ has been settled in 6.2 A, [35]) (Fig. 3C)
indicating that the E7C conformation must change to allow the
nucleophilic attack of the thiolate to occur.
We then evaluated the eﬀect of ROS in the structure of the three E7
proteins. The far UV circular dichroism (CD) spectra of each protein in
the reduced state (0 min incubation) and after one hour of incubation
with H2O2 were recorded (Fig. 3D, E and F). After one hour of reaction
the reduced protein fell below 50% and the appearance of overoxidized
species was minimum (Fig. 3B and Supplementary Figure 2).
The overall secondary structure content of the reduced species was
similar for the HPV16, HPV11 and HPV18 E7 proteins as judged by the
similarity in the FAR-UV CD spectra. After incubating with H2O2 for
1 h only a small (less than 1.5 mdeg) decrease in the negative band at
225 nm was observed for the HPV16, HPV11 and HPV18 E7s.
Although the extent of change could be underrepresented due to the
existence of reduced protein, ROS produces in diﬀerent E7s proteins a
similar conformational change irrespective of the cysteine arrange-
ment.
It should be noted that, at least for the HPV16 E7 protein, this
conformational change should involve a thiolate translation of at least
13 A, that occurs without the rearrangement of the major secondary
elements of the E7 folding architecture (i.e a FAR-UV CD change less
than 1.5 mdeg). To conﬁrm that the FAR-UV CD change was due to the
formation of the C59-S-S-C68 disulﬁde we analyzed the C59/68A
mutant and no FAR-UV CD change was observed (Not shown).
A conformational change that is triggered only after the oxidation of
a ROS-reactive cysteine (i.e to sulfenic acid) is necessary to prevent the
spontaneous oxidation of the protein under basal conditions and may
act as a molecular switch that fulﬁlls ROS sensing proteins [36–38].
Although we were unable to experimentally detect the proposed
sulfenic acid intermediate we hypothesize that a conformational change
is induced by the sulfenic acid formation in a non-canonical cysteine
that brings a second distant non-canonical residue in the proximity to
allow a disulﬁde formation.
3.4. Subcellular localization of the E7 is modulated by oxidation of
non-canonical cysteines
The expression pattern of the HPV16 E7 protein is variable and
depends on the type of expression and cell line [39]. Nuclear import of
HPV16 E7 depends on the interaction of Nup62 nucleoporin with a
hydrophobic amino acid patch, spanning residues 65LRLCV69 in the
CRD domain of HPV16 E7 protein [40]. The non-canonical C68 that
forms a disulﬁde bridge when exposed in vitro to ROS is located at the
very center of the nuclear localization signal (NLS) (Fig. 4A). We thus
evaluated the eﬀect of H2O2 in the sub-cellular localization of spGFP-
E7 wild type (wt) protein transiently expressed in HeLa cells by
confocal ﬂuorescence microscopy.
spGFP-E7wt protein shows a predominantly nuclear localization
(Fig. 4B, panel a). In contrast, when HeLa cells transfected with the
spGFP-E7wt plasmid were treated with H2O2 we observed that the
cytoplasm ﬂuorescence intensity increased (Fig. 4B, panel b) indicating
that the nuclear import and/or export trade-oﬀ was aﬀected by a redox
process. In order to quantify the extent of re-localization, we calculated
the nuclear to cytoplasm ﬂuorescence intensity ratio showing that
incubation of transfected spGFP-E7wt HeLa cells with peroxide led to a
decrease of 25% in the nuclear to cytoplasm ratio (Fig. 4C). The extent
of the spGFP-E7wt redox-based relocalization can be underestimated
due to the existence of many intracellular ROS protecting enzymes such
as peroxiredoxins and catalases that counter the eﬀect of exogenous
peroxide. Furthermore, the formation of the internal disulﬁde (C59-S-
S-C68) is a reversible, dynamic equilibrium that can be readily
displaced to the reduced form by the most abundant low molecular
weight thiols, such as glutathione or by highly eﬀective disulﬁde
reducing enzymes, such as thioredoxin. Notwithstanding the above-
mentioned factors we were able to detect a statistically signiﬁcant
variation on the nuclear-to-cytoplasmatiic ratio upon the induction of
an intracellular oxidative stress.
The spGFP-E7C59A mutant is unable to form the internal disulﬁde
bond (C59-S-S-C68) while maintaining the proposed NLS intact
(65LRLCV69) (Fig. 4A). The nuclear to cytoplasm intensity ratio for
the spGFP-E7C59A (Fig. 4B, panels c and d) remained unchanged after
the incubation of transfected HeLa with peroxide (Fig. 4C), indicating
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that C59 is strictly required for the protein re-localization mediated by
ROS. On the other hand, a control using spGFP transfected HeLa cells
(Fig. 4B, panels e and f) showed that this protein has a pan-cellular
localization albeit with a nuclear preference, and not aﬀected by ROS
(Fig. 4C).
Inmunoblot analysis of expressed HPV16 E7 proteins showed that
proteins were expressed at similar levels and remained unchanged after
peroxide treatment (Fig. 4 D).
3.5. Reactive non-canonical cysteines are critical for ROS sensing
The presence of non-canonical cysteines confers to E7 an increased
sensitivity to ROS, in which an oxidative stimulus leads to the
formation of a disulﬁde bond and to the subcellular re-localization of
the protein. We thus sought for the presence of reactive cysteines,
which show a pKa lower than glutathione (pKa 8.8). As the thiolate is a
better nucleophile than the protonated thiol, a low pKa is a hallmark
feature of ROS sensing cysteines [41]. We evaluated the pH depen-
dence of the E7Δ1-26 HPV16 oxidation with H2O2 by RP-HPLC
(Fig. 5A). At pH 5.0, the protein is insensitive to ROS within one hour,
no OxI and OxII species are observed and the major peak at 29.5 min
corresponds to the reduced protein. As the pH increases, the propor-
tion of species Ox I and Ox II increases at the reduced species expense.
After incubating the E7Δ1-26 with ROS at pH 9.0 for one hour, we
observed that 14% of the protein remains in the reduced state, 30% as
Ox I species and 55% as Ox II. On the other hand, the E7Δ1-26(C59/
68A) is refractory to ROS oxidation after 1 h incubation
(Supplementary Figure 3) and more than 80% of the protein remains
in the reduced state (ROS treatment for 1 h at pH 9.0). This observa-
tion indicates that the reactive cysteine is restricted to C59 and C68
Fig. 3. Kinetics and conformational changes induced by ROS in prototypical alpha HPVs. (A) Schematic representation of the E7 proteins from the HPV16, 18 and 11 strains. Canonical
cysteines are highlighted in green and non-canonical cysteines in red. The position of the non-canonical residues is indicated at the right of each protein. (B) Kinetic decay of the HPV11,
18 and 16 E7 reduced species: HPV11 (black circles), HPV16 (blue circles), and HPV18 (red circles). Apparent t1/2 was calculated by ﬁtting to a single exponential equation. (C)
Measurement of the distance between sulfur atom of the C59 and C68 cysteines (magenta) in the structure of the HPV16 E7 protein. (D, E, F) CD spectra of the reduced HPV16, 11 and
18 proteins, respectively, before (red line) and after the incubation with H2O2 for 60 min (black line). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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residues. It should be noted that, for the double mutant, no Ox II
species is observed and only a trace amounts of Ox I can be detected
through the entire range of pH 5.0–10.0).
The single cysteine C59A and C68A mutants show a similar redox
behavior (Fig. 5B and C). These proteins are ROS sensitive even though
the oxidation mechanism diﬀers from the wild type protein and no Ox
II species are observed. At high pH 8–10), the reduced species decrease
and the Ox I species are clearly accumulated for both proteins, contrary
to that observed for the C59/68A double mutant (Supplementary
Figure 3).
We identiﬁed the cysteine connectivity in Ox II and Ox I species by
trypsin treatment of alkylated HPLC-puriﬁed peaks and subsequent
MALDI-TOF analysis. For better understanding of the data we present
a schematic representation of the tryptic fragments and the possible
connectivity between fragments (Supplementary Figure 4). The Ox II
species contains the internal disulﬁde C59-S-S-C68 as thoroughly
described in Supplementary Figure 5. On the other hand, we identiﬁed
in the Ox I species an internal disulﬁde containing the canonical
cysteines 58 and 61 that are involved in Zn+2 binding (Supplementary
Figure 5).
Although cysteines 58 and 61 are present in the E7Δ1-26(C59/
68A), E7Δ1-26(C59A) and E7Δ1-26(C68A), the presence of an un-
paired cysteine in the C59A or C68A mutant produces higher amounts
of Ox I species when compared with the double mutant. The formation
of the Ox I species is aﬀected by the presence of non-canonical
cysteines showing a crosstalk between canonical and non-canonical
residues.
We calculated the pKa of the reactive cysteine that governs the
formation of the C59-S-S-C68 disulﬁde bond. The appearance of Ox II
species and the decrease of the reduced species were ﬁtted to a two
state model that considers only the protonated and deprotonated
forms. The pKa that governs the formation of Ox II and the decrease
of the reduced species are 6.8 and 6.6, respectively, strongly suggesting
that the oxidation of the reduced species leads to Ox II as main product
(Fig. 5D). At least one of the non-canonical cysteines, the C59 or C68
residue is a reactive cysteine whose pKa is below the pKa of low
molecular weight thiols (Glutathione pKa=8.8 [41]).
3.6. ROS sensing mechanism: lone or multiple reactive cysteines
versus reactive-resolutive cysteine pairs
Our biochemical experiments with E7 proteins from HPV11,
HPV16 and HPV18 strains show a common behavior in spite of
diﬀerent patterns of non-canonical cysteines. This suggests that several
positions in the E7 sequence are degenerate in terms of redox sensing
and that there may be a simple organizing principle behind the diverse
patterns observed in naturally occurring E7 proteins (Fig. 1C). The
oxidation behavior of E7desLXCXE and E7Δ[1–26] shows that the C-
terminal domain of E7 is the main responsible for redox sensing. Thus,
we will focus our analysis on E7C, where cysteines are observed at 4
canonical sequence positions (58, 61, 91 and 94) and 15 non-canonical
sequence positions (51, 53, 55, 56, 57, 59, 62, 63, 66, 68, 71, 77, 87, 93
and 96). Since we are only interested in redox sensing by cysteines, we
considered all non-cysteine residues as equivalent.
First, we considered the ﬁve E7 sequences (6%) that lack non-
canonical cysteines. E7(C59/68A) is insensitive to ROS within the ﬁrst
Fig. 4. Oxidative environment directs subcellular re-localization of spGFP-E7wt. (A) Position of the NLS and NES in the E7C of HPV16. (B) HeLa cells were transiently transfected with
spGFP-E7wt (panels a, b), spGFP-E7C59A (panels c, d) or spGFP (panels e, f) plasmids. For ROS treatment, cells were incubated with 4 mM H2O2 for 1 h prior to ﬁxation (panels b, d,
and f). Cells were examined by confocal ﬂuorescence microscopy at 24 h post-transfection. (C) Ratio of spGFP ﬂuorescence between nuclear and cytoplasmic signal in transfected cells as
in B. a, b, c, d bars not sharing the same superscript are signiﬁcantly diﬀerent (p < 0.05, n=20 cells). (D) HPV16 E7 protein is properly expressed in HeLa cells. Cells were transfected as
in B and lysates were obtained 24 h post-transfection, subjected to SDS-PAGE and transferred to nitrocellulose membrane; blots were probed with anti E7 HPV16 monoclonal antibody.
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hour of incubation, while the wild type protein is readily oxidized
(Fig. 2). Hence, we propose that E7 proteins without non-canonical
cysteines would not be able to respond readily to a redox signal.
We also examined the 29 E7 sequences (37%) that contain only one
non-canonical cysteine. Single non-canonical cysteines are observed at
seven diﬀerent E7 sequence positions [51, 56, 62, 63, 66, 68 and 71].
We propose that E7 proteins with a single non-canonical cysteine
perform redox sensing through a mechanism involving a single reactive
cysteine, similar to that observed for one-cysteine peroxiredoxins [42].
We can use as a model the E7Δ1-26(C59A) protein, that contains
cysteine 68 as the sole non-canonical cysteine. This protein is ROS
sensitive through a mechanism that eventually leads to reversible
formation of an intramolecular disulﬁde bond between Zn-binding
canonical cysteines C58-C61 (Ox I species) (Fig. 5). In the cell, the
reaction may be resolved not by the Zn-binding cysteines as in the Ox I
species but by low molecular weight thiols or other cysteine-containing
proteins, such as thioredoxin. This strongly suggests that these 7
positions are degenerate, i.e., fulﬁll the same role in redox sensing by
E7, and that a single non-canonical cysteine from this group is
suﬃcient for the redox sensing activity. The rest of the E7 sequences
(45 strains) contain more than one non-canonical cysteine and an
alternative mechanism must be proposed.
We have thoroughly analyzed the redox behavior of the HPV16 E7
that contains non-canonical cysteines 59 and 68. In short reaction
Fig. 5. Identiﬁcation of the cysteine pKa and disulﬁde connectivity. (A) Oxidation of HPV16 E7Δ1–26 at diﬀerent pHs resolved by RP-HPLC. R indicates the reduced species peak. The
disulﬁde connectivity responsible for the formation of Ox I and Ox II species are indicated above the corresponding RP-HPLC peak. (B) Oxidation of HPV16 E7Δ1–26 (C59A) at
diﬀerent pHs resolved by RP-HPLC. (C) Oxidation of HPV16 E7Δ1–26 (C68A) at diﬀerent pHs resolved by RP-HPLC. (D) Cysteine pKa calculation was performed in two diﬀerent
transitions. The pKa was determined from the Ox II species (black circles) and the decrease of the reduced peak (red circles) versus the pH plot and ﬁtted to Eq. (3) as described in
methods. The intensity of the reduced species of the double mutant E7Δ1–26 (C59/68 A) versus pH was included as control (blue circles). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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times, this protein can sense ROS via a stepwise mechanism where a
reactive cysteine reacts via nucleophilic substitution with the H2O2
molecule (forming a sulfenic acid [41]) that is then attacked by a
second, resolutive cysteine to form the C59-C68 disulﬁde bond (Ox II
species) (Fig. 5). Since we identiﬁed C68 as a reactive cysteine (see
above), we conclude that C59 is the resolutive cysteine in HPV16 E7. In
accordance with this model, C59 is never the lone non-canonical
cysteine, reinforcing our view that it is not a reactive cysteine in E7
natural sequences. HPV18 E7 contains non-canonical cysteines C59
and C56. Since it behaves similar to HPV16 E7 (Fig. 3), we suggest that
in HPV18 E7 C56 acts as a reactive cysteine and C59 is the resolutive
cysteine. HPV11 E7 contains three non-canonical cysteines: C57, C59
and C71 and also behaves similar to the HPV16 and HPV18 E7
proteins (Fig. 3). We propose that in HPV11 E7, C57 and C71 can both
act as reactive cysteines and C59 is the resolutive cysteine. It follows
from these considerations that the reactive cysteine that pairs with C59
can be located at diﬀerent, degenerate sites of the sequence, similar to
the degeneracy observed for lone reactive cysteines (see previous
section). In total, 27 E7 proteins (34%) contain C59 and we propose
that this group of E7 proteins sense ROS via a stepwise mechanism in
which one or two cysteines located at position 51, 56, 57, 62, 63, 66,
68, 71, 77, 87 or 96 is/are reactive and C59 plays a resolutive role. The
remaining 18 E7 sequences (23%) lack C59 but contain multiple
reactive cysteines at positions 51, 53, 55, 56, 62, 63, 66, 68, 71, 77,
87 or 96. Fifteen E7 sequences contain two reactive non-canonical
cysteines, while three E7 sequences have three reactive non-canonical
cysteines. We hypothesize that this group of E7 proteins perform redox
sensing via the same single-cysteine mechanism, albeit at multiple sites
in the sequence simultaneously.
Our model for redox sensing in E7 can be summarized as follows.
E7 sequences that lack non-canonical cysteines (6%) are not capable of
fast ROS sensing. On the other hand, 59% of the known E7 proteins
perform ROS sensing via a reactive-cysteine mechanism involving one
to three reactive non-canonical cysteines. The remaining E7 proteins
sense ROS by a stepwise mechanism with one or two reactive non-
canonical cysteines and resolutive one (C59).
3.7. Evolution of ROS sensing in HPV E7 proteins
Next, we considered whether the arrangements of non-canonical
cysteines in natural E7 proteins support our model for redox sensing.
Speciﬁcally, we asked if these arrangements diﬀer signiﬁcantly from a
naïve model in which the appearance of non-canonical cysteine
residues at diﬀerent positions in the sequence is uncorrelated and
simply follows the frequencies at the corresponding alignment column
(see methods). The simplest arrangements for ROS sensing suggested
by our model are a single, reactive non-canonical cysteine and a
reactive-resolutive pair involving C59. These two arrangements are
overrepresented in known viral types relative to our naïve model
(Fig. 6A), suggesting that these conﬁgurations of the molecule have
been favored during E7 evolution. The frequency of appearance of
more complex arrangements in agreement with our model, such as two
or three reactive cysteines and C59 together with two reactive
cysteines, does not diﬀer signiﬁcantly from our naïve model
(Fig. 6A). On the other hand, E7 sequences without non-canonical
cysteines, with C59 as the single non-canonical cysteine or with more
than three non-canonical cysteines do not ﬁt with our model for ROS
sensing. In agreement with our view, Fig. 6A shows that these three
arrangements are underrepresented in known viral types relative to our
naïve model, suggesting that these conﬁgurations of the molecule have
been disfavored during E7 evolution. Overall, we ﬁnd that the
distribution of non-canonical cysteines in E7 sequences agrees better
with our proposed mechanisms for redox sensing than with a naïve
model that excludes coordinated evolution of non-canonical cysteines.
In addition to analyzing extant patterns of non-canonical cysteines
in E7, we also performed a reconstruction of the natural history of
redox sensing in E7 proteins. We simpliﬁed the observed patterns of
non-canonical cysteines to six states, in colors in Fig. 6B: no non-
canonical cysteines (white), one reactive cysteine (blue), two reactive
cysteines (green), three reactive cysteines (black), C59 plus one reactive
cysteine (yellow) and C59 plus two reactive cysteines (red). The scheme
in Fig. 6B depicts our proposed mechanism for the evolution of redox
sensing in E7. The top row corresponds to the absence of redox
sensing, the middle row to ROS sensing by one or more reactive
cysteines and the bottom row to ROS sensing by a reactive-resolutive
cysteine pair. We propose that the acquisition or loss of a reactive
cysteine can occur both in the absence and presence of C59, while C59
can appear only in the presence of one or two reactive cysteines. We
used the phylogenetic hypothesis [43] and mapped the six redox
sensing states to the leaves of the tree (Fig. 6C, squares). Using the
Mesquite software, we reconstructed the ancestral redox sensing state
of each internal node of the tree using Fisher parsimony (Fig. 6C,
branch colors). Our reconstruction proposes an ancestral state with a
single reactive cysteine and 22 evolutionary transitions, of which only
in two for species 14 are unresolved (Fig. 6C, orange segment). We
mapped into the scheme in Fig. 6B the number of evolutionary
transitions in our reconstruction (fractional numbers are due to the
two unresolved transitions). Among the proposed transitions, 20.33
(92.4%) are in agreement with our scheme, suggesting that our model
describes the evolution of ROS sensing in E7 well. As a control, we
generated redox state reconstructions starting from 100000 rando-
mized sets of extant states, while keeping the tree structure intact. All
randomized trees show a larger fraction of forbidden transitions
(average 30%, standard deviation 6.3) than the natural tree (7.6%),
further supporting our model. In all, both the analysis of extant
sequences and the reconstruction of ancestral characters agree with
our proposed model for the evolution of ROS sensing in E7 (Fig. 7).
4. Discussion
In this study we propose an integrated mechanism for ROS-sensing
in the E7 oncoprotein from alpha genus papillomavirus, where all the
high-risk strains belong. The redox-homeostasis in HPV-transformed
cells is aﬀected as a consequence to the NOX induction mediated by the
papillomavirus oncoprotein expression [22]. On the other hand, the
development of HPV-induced cancers could take years in a process that
requires, the persistent expression of viral oncogenes [18] (i.e E7)
during which the canonical and non-canonical cysteines are exposed to
a potentially harmful oxidant stimuli. Paradoxically, we observed an
evolutionary acquisition of reactive non-canonical cysteines in most
(94%) of the E7 proteins of alpha genus. Our experimental data
support that the E7s from alpha papillomavirus are able to sense and
respond to redox stimuli (i.e ROS) of host cells and are equally able to
manage the potentially harmful oxidant environment.
We showed that a ROS-reactivity hierarchy exist for the six cysteine
residues present in the CRD domain of the HPV16E7 protein, where
the non-canonical cysteines couple (C59-S-S-C68 form Ox II species) is
the most reactive followed by the canonical cysteine couple C58 and
C61 (form OX I species), while the canonical cysteines C91 and C94
remains unreactive under the assayed experimental conditions. Based
on the pH dependence for the disulﬁde formation between C59 and
C68, non-canonical residues in the HPV16 E7 protein are, by deﬁni-
tion, reactive cysteines with a (thiol) pKa close to 7, one pH unit below
the most abundant glutathione molecule, and with a pKa of 8.8 [41].
We observed that the ROS sensitivity of the E7 proteins from HPV16,
HPV18 and HPV11 strains are comparable albeit with diﬀerent
arrangements of non-canonical cysteines. The multiple non-canonical
cysteines arrangements could evolve from the variable redox environ-
ment that diﬀerent papillomavirus strains suﬀer and aﬀect the ﬁtness
for each virus life cycle.
We observed that the Ox I (C58-S-S-C61) species is increased in
E7Δ1-26C59A or C68A single cysteine mutants when exposed to ROS,
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strongly suggesting a chemical crosstalk between canonical and non-
canonical residues. This observation challenges the notion that the
canonical cysteines involved in Zn binding have only structural roles.
A common property between the HPV16, HPV11 and HPV18 E7
proteins is that they undergo only a small rearrangement of the overall
secondary structure elements upon oxidation that is reﬂected by the
Fig. 6. Evolution of ROS sensing in HPV E7 proteins (A) Distribution of non-canonical cysteines in natural sequences (black bars) and a naïve model that posits independent evolution
of non-canonical cysteines (white bars). Error bars are the standard deviation of 1000 replicas of the naïve model. (B) Proposed mechanism for the evolution of redox sensing in E7. The
top row corresponds to the absence of redox sensing, the middle row to ROS sensing by one or more reactive cysteines and the bottom row to ROS sensing by a reactive-resolutive
cysteine pair. Acquisition of a reactive cysteine can occur both in the absence or presence of C59, while appearance of C59 requires the presence of reactive cysteines. (C) Fitch parsimony
[48] reconstruction of ancestral ROS sensing states of E7 proteins, mapped onto a phylogenetic tree of alpha papillomaviruses [43]. Six states are shown: no non-canonical cysteines
(white), one reactive cysteine (blue), two reactive cysteines (green), three reactive cysteines (black), C59 plus one reactive cysteine (yellow) and C59 plus two reactive cysteines (red). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 7. Schematic representation of the ROS-sensing mechanisms of E7 proteins from alpha genus strains. ROS-insensitive E7s are devoid of non-canonical cysteines. All ROS-sensing
E7s contain a reactive(s) non-canonical cysteine (s). The resolutive cysteine is present in a representative group of ROS-sensing sequences. A conformational change must be present in
all ROS-sensing E7s to mediate signal transduction. Putative intermediates Ox I are enclosed in brackets.
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marginal change observed in the CD spectra of the reduced and
oxidized species. Despite of their diﬀerences in the primary sequences
and cysteine rearrangements a similar change in the CD spectra, with a
small decrease in the intensity of the band centered at 225 nm suggest
a local unfolding, common to all three E7 proteins. For the HPV16 E7
protein we demonstrated that the intramolecular disulﬁde bond
formation between non-canonical cysteine pair (C59-C68) is the major
resultant of ROS and glutathione oxidation [29], a reaction that implies
a long distance movement of the cysteines if we consider the 19.2 A
that separates both sulfur atoms in the dimeric structure [24]. ROS
sensing must therefore involve the formation of a sulfenic acid
intermediate (ROS) or a mixed disulﬁde (GSH) in the reactive cysteine
that trigger the conformational change to allow a nucleophilic sub-
stitution of a second (resolutive) cysteine to form the observed
intramolecular disulﬁde bond. Statistically, 6.3 A is the distance at
which two sulfur atoms have to be settled to form a disulﬁde bridge.
The non-canonical cysteines in the HPV16 E7 protein lay outside the
cut-oﬀ distance value, precluding the spontaneous formation of the
disulﬁde bond in the absence of ROS. As no spontaneous oxidation is
observed for the HPV11 and HPV18 E7s we can infer that reactive
cysteines in these proteins are positioned in such a way that direct
reaction is also precluded. ROS and more generally redox-sensing is
based in the presence of a reactive (low pKa) cysteine and a transduc-
tion mechanism that involves a concerted conformational change.
The highly reactive C68 is central to the NLS for the HPV16 E7 [40]
and hence the internal disulﬁde bond formation functions as a redox-
controlled switch for masking the NLS sequence, a mechanism that is
common to other redox regulated proteins such as Yap 1 [38]. This is a
new level of regulation for the E7 moonlighting and the ﬁrst time that a
direct evidence of redox regulation is proposed for this oncoprotein.
Subcellular localization of the HPV16 E7 protein strongly depends on
the type of expression (i.e transient or constitutive) or cellular origin,
with patterns that can be rather diﬀerent. Transiently expressed non-
fused E7 protein in U2OS cells detected with a speciﬁc antibody [39] or
transiently expressed as a GFP-E7 fusion protein in HeLa cells directly
detected [40], tend to be mostly nuclear. A totally diﬀerent scenario is
observed with the constitutive E7 expression in CasKi cells, or in
cervical cancer adenocarcinoma biopsies [39] where a mostly cytoplas-
matic localization pattern is clearly observed, indicating that the
HPV16 E7 sub-cellular re-localization is a highly regulated process.
The many, yet barely conserved patterns of non-canonical cysteines
in E7 proteins are intriguingly complex (Fig. 1). Our analysis of extant
sequences shows that the cysteine arrangements considered in our
model are strongly favored over other possible arrangements (Fig. 6A).
This strongly suggests that E7 proteins do not present a random
mixture of non-canonical cysteines but a wide set of speciﬁc patterns.
In spite of this complexity, we were able to combine detailed
biochemical and cell biology experiments on paradigmatic E7 proteins
and mutants with analysis of natural sequences (Fig. 6) to propose a
general model for redox sensing by E7 (Fig. 7). In short, there are three
classes of E7 proteins in nature (Fig. 6B). Class 1 E7 proteins are
devoid of non-canonical cysteines and are thus unable of redox sensing.
Class 2 E7 proteins perform redox sensing through one to three
reactive cysteines. The reactive cysteines need not be located at a
speciﬁc sequence position but can appear at a seven diﬀerent sites in
the protein. Class 3 E7 proteins sense changes in the cellular redox
potential by a combination of one or more reactive cysteines and the
single resolutive cysteine C59. In the later case, the reactive cysteines
may be also located at diﬀerent sequence positions. The coexistence of
two or one-cysteine mechanism has been demonstrated for peroxir-
edoxin and methionine sulphoxide reductase enzymes [44,45].
Reactive cysteines in Class 2 and Class 3 E7 proteins constitute a
remarkable departure from the widespread paradigm of protein active
sites appearing always at the same site of the protein.
The fate of the ROS-modiﬁed reactive cysteine can be either the
formation of an internal disulﬁde bond between canonical cysteines of
the Zn-binding motif (i.e C58-S-S-C61) or resolved by cellular redox
molecules (proteins or low molecular weight thiols). The observed
reactive cysteine sites are close in sequence and/or structure to the zinc
binding cysteines [28], which is in agreement by resolution of the ROS-
modiﬁed reactive cysteine through formation of an internal disulﬁde
bond between canonical cysteines of the Zn-binding motif.
From an evolutionary standpoint, our parsimony reconstruction
(Fig. 6C) suggests a Class 2 “reactive cysteine only” ancestral E7
protein. From this ancestral state, the data suggests that both Class 1
“ROS-insensitive” and Class 3 “reactive-resolutive pair” proteins have
appeared multiple independent times during alpha papillomavirus
evolution (4 blue-to-white, 3.67 blue-to-yellow and 1 green-to-red
transitions). Moreover, the number of reactive cysteines in Class 2 and
Class 3 E7 proteins has increased or decreased multiple independent
times during alpha papillomavirus evolution (5 blue-to-green, 2 green-
to-blue, 2 green-to-black and 2.33 yellow-to-red transitions). This high
evolutionary plasticity of non-canonical cysteine patterns in E7 pro-
teins is reminiscent of other pathogen short sequence motifs in E7 and
in other pathogen proteins [46]. We speculate that these trends reﬂect
the diversity of evolutionary pressure present in the evolution of alpha
papillomaviruses, which lead to the observed diversity of redox sensing
states. In addition, cysteine acquisition in E7 can be experimentally
observed in natural intratype variants of HPV52. As reported by Aho
et al., [47] some intratype variants of the HPV52 E7 show a non-
conservative mutation in position 57 (HPV16E7 numeration) that
leads to a replacement of the tyrosine, observed in the prototypical
sequence, to cysteine. It should be noted that position 57 is one of the
most frequently occupied position by non-canonical cysteines (Fig. 1).
Considering that the acquisition of reactive non-canonical cysteines
is common both to the high and low risk HPV strains their presence
must be related to a conserved regulatory function of this protein.
Whether the high prevalence of non-canonical reactive cysteines
observed in the high risk HPV strains is related with the oncogenic
potential of these E7s is unknown, it is clear that these proteins are
exposed to a persistent redox stimulus during the long process of
cellular transformation (the development of HPV-induced cancers
could take years in a process that requires at least, the persistent
expression of viral oncogenes).
E7 is a prototypical transforming protein with many properties
shared by other DNA tumor virus oncoproteins that has evolved to
sense the redox signals of the host cell through the acquisition of
diﬀerent motifs of reactive cysteines.
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